ストックスクリーナーアプリを入手
5.965
1.98%
-0.105
Telomir Pharmaceuticals Inc (TELO) 最新ニュース
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) Sees Significant Increase in Short Interest - MarketBeat
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 2.2% - Defense World
Telomir Pharmaceuticals (NASDAQ:TELO) Trading 2.2% Higher - MarketBeat
What Is Going On With AST SpaceMobile Stock? - Barchart
Experience The Future Of Smart Living With Hisense At IFA 2024 - Barchart
Boeing's troubled space capsule ends mission with a landing in the New Mexico desert, leaving two astronauts in orbit - Barchart
Stakeholder In Trump's Truth Social Parent Company Wins Court Ruling Over Share Transfer - Barchart
Is RTX Corporation Stock Outperforming The S&P 500? - Barchart
US Hiring Rebounds Slightly And Unemployment Rate Dips In Sign Of Still-Slowing Job Market - Barchart
Telegram CEO Defends Himself Against French Charges In First Public Comments - Barchart
New Mexico attorney general sues company behind Snapchat alleging child sexual extortion on the site - Barchart
IGM FINANCIAL INC. ANNOUNCES AUGUST 2024 ASSETS UNDER MANAGEMENT & ADVISEMENT AND NET FLOWS - Barchart
Media AdvisoryPrime Minister's Itinerary For Friday, September 6, 2024 - Barchart
ALIMENTATION COUCHE-TARD INC. ANNOUNCES ELECTION OF DIRECTORS - Barchart
With Musk's X Banned In Brazil, Its Users Carve Out New Digital Homes - Barchart
Telomir Pharmaceuticals’ Age Reversal Drug Shows Promise in Canine Study - Vancity Buzz
Obesity Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Novo Nordisk, Boehringer Ingelheim, Pfizer, BioAge Labs, Aphaia Pharma, Neothetics, NovMetaPharma, Carmot - Barchart
Applications For US Jobless Benefits Fall To 2-Month Low As Layoffs Remain At Healthy Levels - Barchart
WCAS Completes Acquisition Of EquiLend - Barchart
Telomir Pharmaceuticals (NASDAQ: TELO) Featured In Local ABC Exclusive Showing Positive Outcomes Of Proposed Age Reversal Pill In Dogs | FinancialContent Business Page - Financial Content
Soft Tissue Sarcoma Market is expected to grow at a significant CAGR, DelveInsight | Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm - Barchart
FuelCell Energy: Fiscal Q3 Earnings Snapshot - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor - Investing.com India
Unusual Activity In Block Inc. OptionsHighlights SQ Stock's Value - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com Canada
Protecting Homeowners From Unnecessary Financial Stress - Barchart
US Job Openings Fall As Demand For Workers Cools - Barchart
Amyotrophic Lateral Sclerosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Amylyx Pharma, Ionis Pharma, Annexon, Inc., UniQure Biopharma, Sangamo Therapeutics - Barchart
Litecoin May Have Bottomed - Barchart
Telomir names Dr. Itzchak Angel as Chief Scientific Advisor By Investing.com - Investing.com UK
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - Milton Daily Standard
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - AccessWire
Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications - StockTitan
Telomir Pharmaceuticals recruits ex-Synthelabo executive - Investing.com
Eaton Corporation Stock: Is ETN Outperforming The Industrials Sector? - Barchart
Is Union Pacific Corporation Stock Outperforming The Dow? - Barchart
The growth track for Telomir Pharmaceuticals Inc (TELO) has changed recently - SETE News
Quarterly Metrics: Quick and Current Ratios for Telomir Pharmaceuticals Inc (TELO) - The Dwinnex
Regeneron Pharmaceuticals Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Price Up 3.2% - MarketBeat
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Up 3.2% - Defense World
Telomir-1 shows promise in aging dogs, eyes human trials - Investing.com
TELO Stock: Exploring Telomir Pharmaceuticals Inc’s Growth - The InvestChronicle
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Milton Daily Standard
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - Brazosport Facts
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - AccessWire
Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs - StockTitan
Telomir Pharmaceuticals (NASDAQ:TELO) Stock Quotes, Forecast and News Summary - Benzinga
ABC7 Exclusive: New study reveals promising results for age reversal pill on dogs - WWSB
TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q2 2024 - MSN
TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q2 2024 - InvestorPlace
Telomir Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Telomir Pharmaceuticals, Inc. Announces CEO Changes - Marketscreener.com
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman - ForexTV.com
Telomir Pharmaceuticals Chair, CEO Christopher Chapman Passes Away - MarketWatch
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman - StockTitan
Telomir Pharmaceuticals announces passing of CEO Christopher Chapman - TipRanks
Will Telomir Pharmaceuticals (NASDAQ:TELO) Spend Its Cash Wisely? - Simply Wall St
Individual investors are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) biggest owners and were rewarded after market cap rose by US$24m last week - Yahoo Finance
Citius Pharma (NASDAQ:CTXR) Stock Quotes, Forecast and News Summary - Benzinga
Certain Common Stock of Telomir Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 6-AUG-2024. - Marketscreener.com
What Are Wall Street Analysts' Target Price For Abbvie Stock? - Barchart
Carnival Corporation Stock: Analyst Estimates & Ratings - Barchart
Telomir Pharmaceuticals, Inc.'s Lock-Up Period Will End on August 7th (NASDAQ:TELO) - MarketBeat
Telomir Pharmaceuticals, Inc.’s Lock-Up Period Will Expire on August 7th (NASDAQ:TELO) - Defense World
Helix Acquisition Corp. II’s (NASDAQ:HLXB) Lock-Up Period Set To Expire on August 7th - Defense World
Telomir Pharmaceuticals (NASDAQ:TELO) Trading Down 2.6% - MarketBeat
1.25%
1.76%
大文字化:
|
ボリューム (24 時間):